C Champions Oncology Inc
C
Gesloten
SectorGezondheidszorg
5.76 -2.21
Overzicht
Wijziging aandelenprijs
24u
Min
5.58
Max
5.76
Inkomsten | -514K -278K |
|---|---|
Verkoop | 1.5M 17M |
K/W Sectorgemiddelde | 35.118 56.269 |
EPS | -0.02 |
Winstmarge | -1.679 |
Werknemers | 213 |
EBITDA | -508K 104K |
Volgende Winsten | 22 jul 2026 |
|---|
Marktkapitalisatie | 9.2M 92M |
|---|---|
Vorige openingsprijs | 7.97 |
Vorige sluitingsprijs | 5.76 |
Nieuwssentiment
By Acuity
50%
50%
156 / 342 Rangschikking in Healthcare
Champions Oncology Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Champions Oncology Inc Prognose
Sentiment
By Acuity
156 / 342 Rangschikking in Gezondheidszorg
Nieuwssentiment
Neutral
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Onder gemiddelde
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.